Genetic Analysis of a Unique Human Immunodeficiency Virus Type 1 (HIV-1) with a Primer Binding Site Complementary to tRNA(Met) Supports a Role for U5-PBS Stem-Loop RNA Structures i...

nork Kang, Sang-Moo, Morrow, Casey D.
Argitaratua 1999

Enhancement of Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus

nork Kang, Sang-Moo, Compans, Richard W.
Argitaratua 2003

Host responses from innate to adaptive immunity after vaccination: Molecular and cellular events

nork Kang, Sang-Moo, Compans, Richard W.
Argitaratua izan da Mol Cells (2009)

Immunology and efficacy of MF59-adjuvanted vaccines

nork Ko, Eun-Ju, Kang, Sang-Moo
Argitaratua izan da Hum Vaccin Immunother (2018)

Novel vaccines against influenza viruses

nork Kang, Sang-Moo, Song, Jae-Min, Compans, Richard W.
Argitaratua 2011

Virus-like particles as universal influenza vaccines

nork Kang, Sang-Moo, Kim, Min-Chul, Compans, Richard W
Argitaratua 2012

Protective CD8 T cell mediated immunity against influenza A virus infection following influenza virus-like particle vaccination

nork Hemann, Emily A., Kang, Sang-Moo, Legge, Kevin L.
Argitaratua 2013

Microneedle and mucosal delivery of influenza vaccines

nork Kang, Sang-Moo, Song, Jae-Min, Kim, Yeu-Chun
Argitaratua izan da Expert Rev Vaccines (2012)

Oral vaccination with inactivated influenza vaccine induces cross-protective immunity

nork Quan, Fu-Shi, Compans, Richard W., Kang, Sang-Moo
Argitaratua izan da Vaccine (2011)

Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B

nork Kang, Sang-Moo, Yao, Qizhi, Guo, Lizheng, Compans, Richard W.
Argitaratua 2003

Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies

nork Mohan, Teena, Berman, Zachary, Kang, Sang-Moo, Wang, Bao-Zhong
Argitaratua izan da Sci Rep (2018)

Universal influenza vaccines: From viruses to nanoparticles

nork Wang, Ye, Deng, Lei, Kang, Sang-Moo, Wang, Bao-Zhong
Argitaratua izan da Expert Rev Vaccines (2018)

Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus

nork Quan, Fu-Shi, Huang, Chunzi, Compans, Richard W., Kang, Sang-Moo
Argitaratua 2007

Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice

nork Quan, Fu-Shi, Vunnava, Aswani, Compans, Richard W., Kang, Sang-Moo
Argitaratua 2010

Cutaneous immunization: an evolving paradigm in influenza vaccines

nork Gill, Harvinder S, Kang, Sang-Moo, Quan, Fu-Shi, Compans, Richard W
Argitaratua 2014

Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome

nork Shin, Chong-Hyun, Kim, Ki-Hye, Jeeva, Subbiah, Kang, Sang-Moo
Argitaratua izan da Cells (2021)

Preferential Completion of Human Immunodeficiency Virus Type 1 Proviruses Initiated with tRNA(3)(Lys) rather than tRNA(1,2)(Lys)

nork Zhang, Zhijun, Yu, Qin, Kang, Sang-Moo, Buescher, James, Morrow, Casey D.
Argitaratua 1998

Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens

nork Kang, Sang-Moo, Guo, Lizheng, Yao, Qizhi, Skountzou, Ioanna, Compans, Richard W.
Argitaratua 2004

Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

nork Quan, Fu-Shi, Compans, Richard W., Nguyen, Huan H., Kang, Sang-Moo
Argitaratua 2008

Influenza vaccines based on virus-like particles

nork Kang, Sang-Moo, Song, Jae-Min, Quan, Fu-Shi, Compans, Richard W.
Argitaratua 2009